Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2000
08/29/2000US6110743 Vector having at least two oncogenes, a pair of genetic elements which are recombination sites flanking the oncogenes, and another gene; for transformed cells which produce insulin and can be transplanted into human diabetic patients
08/29/2000US6110719 Phytase
08/29/2000US6110706 Amino acid sequences; for increased immunogenicity
08/29/2000US6110700 Nucleic acids that code a modulator of kinase activity; for the diagnosis tumorous condition; for development of models for the evaluation cancer in organ and tissues
08/29/2000US6110694 Methods for determining complexes of tumor rejection antigens and HLA-Cw*160/molecules
08/29/2000US6110690 SODD-specific antibodies and methods
08/29/2000US6110686 DNA hybridizing to a human cystatin-like protein (CSTIN)
08/29/2000US6110672 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
08/29/2000US6110662 HTLV-I/HTLV-II assay and method
08/29/2000US6110469 Hybrid plasmid for 38 kDa antigen of M. tuberculosis
08/29/2000US6110467 Isolated porcine respiratory and reproductive virus, vaccines and methods of protecting a pig against a disease caused by a porcine respiratory and reproductive virus
08/29/2000US6110460 Methods of using morphogen analogs
08/29/2000CA2034487C Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi
08/29/2000CA2015687C Human serum albomin fusion polypeptide
08/29/2000CA2010275C Pancreatic islet cell antigens obtained by molecular cloning
08/29/2000CA1341090C Vampire bat plasminogen activators
08/26/2000CA2296792A1 Expressed sequence tags and encoded human proteins
08/24/2000WO2000049413A2 Rapid assay for arthropod-borne disease vectors and pathogens
08/24/2000WO2000049162A2 Compositions and methods for non-targeted activation of endogenous genes
08/24/2000WO2000049153A1 Fucosyl transferase gene
08/24/2000WO2000049049A1 An antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid
08/24/2000WO2000049046A1 Novel g protein-coupled receptor protein and dna thereof
08/24/2000WO2000049043A2 Human lipid-associated proteins
08/24/2000WO2000049038A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof
08/24/2000WO2000048638A2 Multi-mutant diphtheria toxin vaccines
08/24/2000WO2000048620A1 Yeast cell wall peptides and antibodies thereto
08/24/2000WO2000048595A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
08/24/2000WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use
08/24/2000WO2000015796A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/24/2000WO2000015772A9 Recombinant protein production in urine
08/24/2000WO2000012685A3 Genes associated with neurotransmitter processing
08/24/2000WO1999057280A3 Neisseria meningitidis antigens and compositions
08/24/2000WO1999042828A3 Treating cancer
08/24/2000WO1998024898A3 Therapeutic composition comprising the kal protein and use of the kal protein
08/24/2000DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha
08/24/2000DE19907726A1 Preparation of protein hydrolysates useful in foodstuffs and pharmaceuticals comprises protein homogenization in presence of protease, addition of other proteases and heat inactivation at acidic pH
08/24/2000DE19907725A1 Production of protein isolates in good yield and purity using an extraction process which involves the use of a gradient of protease concentration, pH and temperature
08/24/2000DE19907723A1 Preparation of vegetable protein concentrates, especially soya protein concentrate, with improved protein contents and with production of animal feeds as by-products
08/24/2000CA2371821A1 Novel g protein-coupled receptor protein and dna thereof
08/24/2000CA2371799A1 Yeast cell wall peptides and antibodies thereto
08/24/2000CA2364267A1 Compositions and methods for non-targeted activation of endogenous genes
08/24/2000CA2362807A1 Multi-mutant diphtheria toxin vaccines
08/24/2000CA2362538A1 Secreted proteins and polynucleotides encoding them
08/24/2000CA2362330A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
08/24/2000CA2362300A1 Human lipid-associated proteins
08/24/2000CA2359075A1 An antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid
08/24/2000CA2262056A1 Composition, methods and reagents for the synthesis of a soluble form of human pex
08/23/2000EP1029917A1 The LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus
08/23/2000EP1029915A2 Expression of G protein coupled receptors in yeast
08/23/2000EP1029914A2 Growth hormone-regulated growth marker gene
08/23/2000EP1029870A2 Hybrid Immunoglobulins
08/23/2000EP1029550A1 Preventives and remedies for diffuse lung diseases
08/23/2000EP1029080A1 Human blood bacterium
08/23/2000EP1029058A1 Dna demethylase, therapeutic and diagnostic uses thereof
08/23/2000EP1029057A1 Reovirus-derived proteins, nucleic acids encoding same, and uses therefor
08/23/2000EP1029054A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
08/23/2000EP1029049A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use
08/23/2000EP1029046A2 Wnt-1 inducible genes
08/23/2000EP1029045A2 EXTENDED cDNAs FOR SECRETED PROTEINS
08/23/2000EP1029044A1 Tissue cement proteins from rhipicephalus appendiculatus
08/23/2000EP1029041A2 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
08/23/2000EP1029040A1 Method of increasing efficiency of directed evolution of a gene using phagemid
08/23/2000EP1029033A1 MURD PROTEIN AND GENE OF $i(STREPTOCOCCUS PYOGENES)
08/23/2000EP1028978A2 Glycosylated antibodies and antibody fragments having reactive ketone groups
08/23/2000EP1028976A2 Method for obtaining biologically active dimers of recombinant human growth factors from the cysteine knot family, use of dimers thus obtained
08/23/2000EP1028972A2 MULTI-MER PEPTIDES DERIVED FROM $i(HEPATITIS C VIRUS) ENVELOPE PROTEINS FOR DIAGNOSTIC USE AND VACCINATION PURPOSES
08/23/2000EP1028751A1 Methods and compositions comprising glycoprotein glycoforms
08/23/2000EP1007727A4 Method of dna shuffling with polynucleotides produced by blockingor interrupting a synthesis or amplification process
08/23/2000CN1264427A Osteoprotegernin binding proteins and receptors
08/23/2000CN1264426A Ligand 0(cluding antibody) for display aimed-at endocrine cell reactivity
08/23/2000CN1264425A Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
08/23/2000CN1263946A Synthetic insecticide crystalline protein gene
08/23/2000CN1263945A American pig reproduction and respiratory syndrome (PRRS) virus and its use
08/23/2000CN1055702C Extraction of cell-bound protein from bordetella
08/23/2000CN1055699C Sulfomycin analogue
08/22/2000US6107541 PRAD1 transgenic mice
08/22/2000US6107473 Kringle-related clone HTHBZ47
08/22/2000US6107472 Receptor-type tyrosine kinase-like molecules
08/22/2000US6107469 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
08/22/2000US6107463 Amino acid sequence of protein involved in bacterial two component signal transduction systems; bactericides and bacteriostats especially against staphylococcus
08/22/2000US6107457 Bcr-abl peptide having tyrosine from position 177 and/or tyrosine from position 283; suppresses induction of ras protein; anticarcinogenic agents for leukemia; enriching bone marrow stem cells prior to transplantation
08/22/2000US6107271 Neuroactive peptides
08/22/2000US6107090 Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
08/22/2000US6107088 XAF genes and polypeptides: methods and reagents for modulating apoptosis
08/22/2000US6107086 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
08/22/2000US6107073 Kinase capable of site-specific phosphorylation of IκBα
08/22/2000US6107071 Polynucleotide or complementary sequence which codes for a specific staphylococcus aureus amino acid sequence; for diagnosis of bacterial infections; screening of bactericides, bacteriostats, and antibiotics
08/22/2000US6107059 Peptide library and screening method
08/22/2000US6107055 Method and device for carrying out biochemical reactions
08/22/2000US6107051 Evaluation of propagation capacity in plants; monitoring the amount of soluble polypeptide in endosperm
08/22/2000US6107045 Antibodies to lipoproteins and apolipoproteins and methods of use thereof
08/22/2000US6106842 Extraction of cell-bound protein from bordetella
08/22/2000US6106834 Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
08/22/2000US6106833 Bispecific antibodies, methods of production and use thereof
08/22/2000CA2176494C Purification of hemoglobin
08/22/2000CA2016627C Proteinase inhibitors, process for the preparation thereof and medicaments containing these
08/17/2000WO2000047775A1 Selection of proteins using rna-protein fusions
08/17/2000WO2000047751A1 Intein-mediated protein ligation of expressed proteins
08/17/2000WO2000047749A1 Heat-inducible promoter
08/17/2000WO2000047745A1 The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus